Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Semaglutidea medication originally designed for type 2 diabetes that is now making headlines for its remarkable effectiveness in weight loss
Key Research Characteristics: Selective GH pulse stimulation with minimal off-target hormonal effects Pentapeptide structure: Aib-His-D-2-Nal-D-Phe-Lys-NH Studied in contexts involving GH deficiency, muscle wasting, and metabolic research Compatible with standard reconstitution protocols using bacteriostatic water Specifications: Form: Lyophilised powder Storage: Refrigerate at 28C
10.1093/ehjcvp/pvy011 39 JastreboffA
Regulation of mitochondrial NADP+-dependent isocitrate dehydrogenase activity by glutathionylation
Compound-specific effects are those related to their differing chemistries and/or pharmacokinetic profiles
10.1128/EC.00414-06 Eukaryot
US$ 29.04
US$ 29.86
US$ 28.97
US$ 20.51
US$ 27.71
